4.4 Article

Rehospitalization and survival for stroke patients in managed care and traditional Medicare plans

Journal

MEDICAL CARE
Volume 43, Issue 9, Pages 902-910

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/01.mlr.0000173597.97232.a0

Keywords

aging; cerebrovascular disease; managed care; Medicare; stroke

Funding

  1. NIA NIH HHS [R01-AG19747, R01 AG019747] Funding Source: Medline

Ask authors/readers for more resources

Background: Stroke affects more than 500,000 older persons each year in the United States, but no studies have compared older stroke patients in Medicare health maintenance organizations (HMOs) and fee-for-service (FFS) after recent changes in FFS reimbursement. Objectives: We sought to compare utilization and outcomes after stroke in Medicare HMO and FFS. Design: We reviewed administrative data in I 1 regions from Medicare and a large national health plan. Subjects: We studied Medicare beneficiaries 65 years and older discharged with ischemic stroke during 1998-2000, ie, 4816 HMO patients and a random sample of 4187 FFS patients from 422 hospitals. Measures: We measured survival, rehospitalization, length of stay, discharge destination, and warfarin use. Results: Overall, HMO patients were younger, male, non-Caucasian, and had fewer comorbid conditions. When compared with FFS patients, HMO patients were more likely to be rehospitalized within 30 days for a primary diagnosis of ischemic stroke (Adjusted Hazard Ratio = 1.45, 95% Confidence Interval [CI] 1.14-1.83) or illdefined conditions (eg, rehabilitation services) (2.87, 95% CI 1.854.46) and less likely to be rehospitalized for fluid and electrolyte disorders (0.54, 95% CI 0.34-0.87) or circulatory/respiratory problems (0.77, 95% CI 0.60-0.98). There were no consistent differences in 30-day mortality or in 1-year rehospitalization or mortality for 30-day survivors. HMO patients also were much less likely to be discharged to rehabilitation facilities, slightly less likely to be discharged to skilled nursing facilities and to have a shorter length of stay, and did not differ in the use of home care services or warfarin use when compared with FFS patients. Conclusions: Traditional measures of quality such as 30-day rehospitalization may not be valid when comparing HMO and FFS patients if differences might reflect an alternative service mix. Utilization of postacute care for FFS patients appears similar to HMO patients except for discharge to rehabilitation facilities.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available